Neovii Is An Independent Global Biopharmaceutical Company Based In Rapperswilswitzerlandfounded In 2013It Has Roots Dating Back To 1979 Through Its Predecessor Entitiesneovii Focuses On Developing And Marketing Innovative Therapiesparticularly In The Fields Of Organ Transplantation And Hematology Oncologythe Company Operates In Over 50 Countries And Is A Fully Integratedcommercial Stage Organization Neovii Specializes In Polyclonal Antibody Immunosuppressive Therapieswith A Notable Product Being Grafalona A Rabbit Anti Human T Lymphocyte Globulinatlg Grafalon Has Been Used For Over 30 Years To Prevent Graft Versus Host Disease In Stem Cell Transplantation And To Treat Organ Rejection And Aplastic Anemianeovii Collaborates With Healthcare Professionals Worldwide And Has Established Significant Partnershipsincluding An Exclusive Agreement With Fosun Pharma For The Development And Commercialization Of Grafalon In Several Regionsthe Company Is Committed To Improving Patient Outcomes Through Research And Development Of Novel Therapies
No conferences found for this company.
| Company Name | Neovii Biotech Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
